Ellume Faces Class-Action Suit After Class I Recall Of COVID-19 Tests
Executive Summary
The lawsuit, filed in Maryland federal court, says Ellume should’ve offered refunds to people who bought later-recalled COVID-19 tests from the company.
You may also be interested in...
Recall Of Millions Of Ellume COVID-19 Tests High-Risk Class I, FDA Says
Ellume recalled 2,212,335 of the home tests because there’s a chance they can give false-positive results.
OIG: FDA’s EUA Approach Allowed Bad Tests To Reach Market
A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.
US FDA Finalizes Medical Device Electronic Submissions Guidance
The guidance document explains the history of and requirements for electronic submissions of 510(k)s.